Ischemic stroke biomarkers in blood

Lena Rothstein, Glen C. Jickling

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Ischemic stroke is a leading cause of adult disability and mortality. With over 15 million strokes occurring every year in the world, methods to better identify patients at risk for stroke are needed, as are methods to improve patient diagnosis and prognosis when stroke occurs. Use of blood-based biomarkers is one method that has been evaluated to predict risk of stroke, diagnose stroke and its causes, predict stroke severity and outcome, and guide prevention therapy. Markers that have been identified include a variety of proteins, nucleic acids and lipids that relate to stroke pathophysiology. The role of blood biomarkers in ischemic stroke is still being defined, and further study is needed to develop blood biomarkers for clinical stroke use. In this review, the authors provide a summary of biomarkers that have been divided by their potential clinical application.

Original languageEnglish (US)
Pages (from-to)37-47
Number of pages11
JournalBiomarkers in Medicine
Volume7
Issue number1
DOIs
StatePublished - Feb 2013

Fingerprint

Biomarkers
Blood
Stroke
Nucleic Acids
Lipids
Proteins
Mortality

Keywords

  • biomarkers
  • blood
  • gene expression
  • ischemic stroke

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Drug Discovery

Cite this

Ischemic stroke biomarkers in blood. / Rothstein, Lena; Jickling, Glen C.

In: Biomarkers in Medicine, Vol. 7, No. 1, 02.2013, p. 37-47.

Research output: Contribution to journalArticle

Rothstein, L & Jickling, GC 2013, 'Ischemic stroke biomarkers in blood', Biomarkers in Medicine, vol. 7, no. 1, pp. 37-47. https://doi.org/10.2217/bmm.12.104
Rothstein, Lena ; Jickling, Glen C. / Ischemic stroke biomarkers in blood. In: Biomarkers in Medicine. 2013 ; Vol. 7, No. 1. pp. 37-47.
@article{89c2cda2a4734218b112687a0b4b4544,
title = "Ischemic stroke biomarkers in blood",
abstract = "Ischemic stroke is a leading cause of adult disability and mortality. With over 15 million strokes occurring every year in the world, methods to better identify patients at risk for stroke are needed, as are methods to improve patient diagnosis and prognosis when stroke occurs. Use of blood-based biomarkers is one method that has been evaluated to predict risk of stroke, diagnose stroke and its causes, predict stroke severity and outcome, and guide prevention therapy. Markers that have been identified include a variety of proteins, nucleic acids and lipids that relate to stroke pathophysiology. The role of blood biomarkers in ischemic stroke is still being defined, and further study is needed to develop blood biomarkers for clinical stroke use. In this review, the authors provide a summary of biomarkers that have been divided by their potential clinical application.",
keywords = "biomarkers, blood, gene expression, ischemic stroke",
author = "Lena Rothstein and Jickling, {Glen C.}",
year = "2013",
month = "2",
doi = "10.2217/bmm.12.104",
language = "English (US)",
volume = "7",
pages = "37--47",
journal = "Biomarkers in Medicine",
issn = "1752-0363",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Ischemic stroke biomarkers in blood

AU - Rothstein, Lena

AU - Jickling, Glen C.

PY - 2013/2

Y1 - 2013/2

N2 - Ischemic stroke is a leading cause of adult disability and mortality. With over 15 million strokes occurring every year in the world, methods to better identify patients at risk for stroke are needed, as are methods to improve patient diagnosis and prognosis when stroke occurs. Use of blood-based biomarkers is one method that has been evaluated to predict risk of stroke, diagnose stroke and its causes, predict stroke severity and outcome, and guide prevention therapy. Markers that have been identified include a variety of proteins, nucleic acids and lipids that relate to stroke pathophysiology. The role of blood biomarkers in ischemic stroke is still being defined, and further study is needed to develop blood biomarkers for clinical stroke use. In this review, the authors provide a summary of biomarkers that have been divided by their potential clinical application.

AB - Ischemic stroke is a leading cause of adult disability and mortality. With over 15 million strokes occurring every year in the world, methods to better identify patients at risk for stroke are needed, as are methods to improve patient diagnosis and prognosis when stroke occurs. Use of blood-based biomarkers is one method that has been evaluated to predict risk of stroke, diagnose stroke and its causes, predict stroke severity and outcome, and guide prevention therapy. Markers that have been identified include a variety of proteins, nucleic acids and lipids that relate to stroke pathophysiology. The role of blood biomarkers in ischemic stroke is still being defined, and further study is needed to develop blood biomarkers for clinical stroke use. In this review, the authors provide a summary of biomarkers that have been divided by their potential clinical application.

KW - biomarkers

KW - blood

KW - gene expression

KW - ischemic stroke

UR - http://www.scopus.com/inward/record.url?scp=84873421554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873421554&partnerID=8YFLogxK

U2 - 10.2217/bmm.12.104

DO - 10.2217/bmm.12.104

M3 - Article

C2 - 23387483

AN - SCOPUS:84873421554

VL - 7

SP - 37

EP - 47

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

SN - 1752-0363

IS - 1

ER -